Caisse de depot et placement du Quebec Buys Shares of 4,448,107 Merck KGaA $MKGAF

Posted by Stanley Muller on Aug 26th, 2026

Caisse de depot et placement du Quebec purchased a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 4,448,107 shares of the company’s stock, valued at approximately $571,582,000. Merck KGaA makes up approximately 0.8% of Caisse de depot et placement du Quebec’s portfolio, making the stock its 26th biggest holding.

Other hedge funds also recently modified their holdings of the company. Frazier Financial Advisors LLC acquired a new stake in Merck KGaA during the 2nd quarter worth approximately $25,000. Rakuten Securities Inc. bought a new stake in Merck KGaA in the 2nd quarter valued at $27,000. Solstein Capital LLC acquired a new position in Merck KGaA in the 2nd quarter worth $33,000. Delos Wealth Advisors LLC bought a new position in Merck KGaA during the 2nd quarter worth about $33,000. Finally, Burk Holdings LLC bought a new position in Merck KGaA during the 2nd quarter worth about $39,000. Institutional investors and hedge funds own 0.10% of the company’s stock.

Merck KGaA Stock Performance

Shares of Merck KGaA stock opened at $164.00 on Wednesday. The firm has a market cap of $21.20 billion, a price-to-earnings ratio of 25.04 and a beta of 0.96. The stock’s 50-day moving average is $163.08 and its 200-day moving average is $148.69. Merck KGaA has a one year low of $116.68 and a one year high of $175.56. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84.

About Merck KGaA

(Free Report)

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.